BlueScope CEO Mark Vassella says the steelmaker is in great shape. | South Coast Register
BlueScope's Australian CEO Mark Vassella says the company can still profit in downturns that would in the past have seen it lose money.
Stay updated with breaking news from Dapto. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BlueScope's Australian CEO Mark Vassella says the company can still profit in downturns that would in the past have seen it lose money.
Aptose Biosciences Inc. (NASDAQ:APTO – Get Free Report) (TSE:APS) was the recipient of a significant increase in short interest during the month of January. As of January 31st, there was short interest totalling 192,600 shares, an increase of 31.9% from the January 15th total of 146,000 shares. Currently, 6.2% of the shares of the stock […]
Lake Illawarra Police District's list of wanted people includes Justin Austin, Justin Heyman, Sheree Bell, Kelly Treble, Geoffrey Maher and Luke Heyligers.
Residents trapped in a Warrawong apartment fire were saved by the quick-thinking actions of the first fire crew on the scene.
Aptose Biosciences (NASDAQ:APTO – Get Free Report) and Genocea Biosciences (NASDAQ:GNCAQ – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and profitability. Analyst Ratings This is a summary of […]